Delivery Order SPE2DB24D2100-SPE2DB25FBEJX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,094.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price contract utilizes no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $12,429.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract was awarded competitively and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,890.69 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,388.24 delivery order to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) with an ultimate completion date of September 29, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,146.35 for Adderall XR 20 mg capsules (100 count) on June 2, 2025, with completion scheduled for June 3, 2025. This contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's significantly larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,764.74 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100 count) on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract ceiling value of $3,433.81. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract ceiling value of $1,604.40. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) valued at $1,592.16. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) valued at $2,984.62. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBEJXDelivery Order
The Defense Logistics Agency awarded a $3,683.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) on May 27, 2025, with an ultimate completion date of May 28, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the DLA encompasses a wide spectrum of therapeutic products, including neurological treatments, diabetes medications, pain management pharmaceuticals, antibiotics, and specialized medical supplies. The firm's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its role as a prime vendor under the DLA's global pharmaceutical support framework, positions it as a key supplier for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 5/27/25 |